DocDollars

Akcea Therapeutics, Inc.

MA · United States · Reporting entity ID 100000476820

Total reported 2019–2025
$13.1M
#424 of 2,960 reporting companies — 0% of all reported industry payments
$2.30M in general payments across 9,245 records, plus $10.8M in research funding across 1,876 records.

How it breaks down

General payments $2,300,929
Research funding $10,793,630

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Akcea Therapeutics, Inc. reported $13.1M to US doctors and teaching hospitals from 2019 to 2025, ranking #424 of 2,960 reporting companies. 82% of that was research funding and 18% general payments such as consulting, speaking, food and travel. 9,245 general payment records and 1,876 research records were filed.

Common questions about Akcea Therapeutics, Inc.

How much has Akcea Therapeutics, Inc. paid US doctors?

Akcea Therapeutics, Inc. reported $13,094,559 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $2,300,929 in general payments, $10,793,630 in research funding.

How does Akcea Therapeutics, Inc. rank among drug and device companies?

It ranks #424 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Akcea Therapeutics, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.